SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001999371-24-000734
Filing Date
2024-01-23
Accepted
2024-01-23 17:22:31
Documents
13
Period of Report
2024-01-22
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT dmk_8k-012224.htm   iXBRL 8-K 26376
2 AMENDED AND RESTATED BYLAWS OF DMK PHARMACEUTICALS CORPORATION ex3-1.htm EX-3.1 143926
  Complete submission text file 0001999371-24-000734.txt   378517

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE dmk-20240122.xsd EX-101.SCH 3042
4 XBRL LABEL FILE dmk-20240122_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE dmk-20240122_pre.xml EX-101.PRE 22378
7 EXTRACTED XBRL INSTANCE DOCUMENT dmk_8k-012224_htm.xml XML 3397
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
DMK PHARMACEUTICALS Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 24553563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)